Streetbeat News

Stock Prices

PHX

PHX Minerals (NYSE:PHX) reported Q3 2024 earnings of $0.04 per share, beating the analyst estimate of $0.01 by 300%. Sales were $9.541 million, surpassing the $8.123 million estimate by 17.46% and marking a 26.77% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:54 pm

ASPN

Aspen Aerogels (NYSE:ASPN) reported Q2 2024 earnings per share of $0.03, missing the analyst estimate of $0.05 by 40%. However, the company reported sales of $117.8 million, beating the estimate of $101.2 million by 16.4% and marking a 144.61% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:53 pm

EE

Excelerate Energy has raised its 2024 adjusted EBITDA guidance to a range of $320 million to $340 million.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:53 pm

PACB

Pacific Biosciences (NASDAQ:PACB) reported Q2 2024 adjusted EPS of $(0.20), beating the estimate of $(0.23). However, sales of $36.013M missed the $40.878M estimate and were down 24.30% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:53 pm

STR

Sitio Royalties (NYSE:STR) reported Q2 2024 earnings per share (EPS) of $0.15, missing the analyst consensus estimate of $0.20 by 25%. However, the company reported quarterly sales of $168.548 million, beating the analyst consensus estimate of $161.800 million by 4.17%. This represents a 23.51% increase over sales of $136.466 million in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:52 pm

METC

Ramaco Resources (NASDAQ:METC) reported Q2 2024 adjusted EPS of $0.08, significantly beating the analyst estimate of $(0.01). The company also reported sales of $155.30 million, surpassing the $150.23 million estimate and marking a 12.97% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:52 pm

CPRX

Catalyst Pharmaceuticals (NASDAQ:CPRX) reported Q2 2024 adjusted EPS of $0.56, significantly beating the estimate of $0.26. Sales also surpassed expectations, reaching $122.710 million against the $111.866 million estimate. Both EPS and sales showed notable year-over-year growth.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:52 pm

SPCE

Virgin Galactic Holdings (NYSE: SPCE) reported better-than-expected Q2 2024 results with a GAAP EPS of $(4.36), beating the estimate of $(4.93). The company also reported sales of $4.220 million, surpassing the $3.361 million estimate and showing a 125.55% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:51 pm

ROOT

Root (NASDAQ:ROOT) reported Q2 2024 GAAP EPS of $(0.52), beating the analyst estimate of $(1.93) by 73.06%. Sales were $289.2M, surpassing the $264.771M estimate by 9.23%. This marks a significant improvement from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:50 pm

SM

SM Energy shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 07, 2024 | 8:50 pm